We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen, Wyeth To Fight Suit Over Aranesp, Enbrel

Law360 (February 27, 2009, 12:00 AM EST) -- A qui tam suit against Amgen Inc., Wyeth Pharmaceuticals Inc. and others over allegedly unlawful marketing activities in connection with Amgen's anemia drug Aranesp and the psoriasis and arthritis drug Enbrel,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.